Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fentanyl 67microgram sublingual tablets sugar free
0407020A0AACHCH
|
Fentanyl | Fentanyl | Central Nervous System | 4 |
|
Fentanyl 50micrograms/dose nasal spray
0407020A0AABHBH
|
Fentanyl | Fentanyl | Central Nervous System | 1 |
|
Fentanyl 133microgram sublingual tablets sugar free
0407020A0AABXBX
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 200microgram buccal films sugar free
0407020A0AABTBT
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 200micrograms/dose nasal spray
0407020A0AABLBL
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 267microgram sublingual tablets sugar free
0407020A0AABZBZ
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 400microgram buccal films sugar free
0407020A0AABUBU
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 533microgram sublingual tablets sugar free
0407020A0AABYBY
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
|
Fentanyl 800microgram buccal films sugar free
0407020A0AABVBV
|
Fentanyl | Fentanyl | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.